Boston Private Bank & Trust’s Idexx Laboratories IDXX Stock Holding History

Boston Private Bank & Trust’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$1.64M	Sell	21,186 -250	-1%	-$19.5K	0.08%	200
2014 Q4	$1.59M	Sell	21,436 -708	-3%	-$49.6K	0.07%	201
2014 Q3	$1.3M	Sell	22,144 -130	-0.6%	-$8.22K	0.06%	216
2014 Q2	$1.49M	Sell	22,274 -350	-2%	-$22.3K	0.07%	206
2014 Q1	$1.37M	Buy	22,624 +100	+0.4%	+$5.96K	0.07%	211
2013 Q4	$1.2M	Sell	22,524 -2,020	-8%	-$106K	0.06%	222
2013 Q3	$1.22M	Sell	24,544 -630	-3%	-$30.3K	0.07%	212
2013 Q2	$1.13M	Buy	+25,174	New	+$1.1M	0.07%	216

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Private Bank & Trust's IDXX Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its Idexx Laboratories (IDXX) stake by 1.2% in Q1 2015, selling an estimated $19.5K and leaving 21,186 shares worth $1.64M. The position accounts for 0.08% of the portfolio, ranked #200.

Boston Private Bank & Trust first reported a position in IDXX in Q2 2013 and has held it in 8 quarters since. 344 funds tracked by Wall St. Rank hold IDXX as of Q1 2015.

Boston Private Bank & Trust held 21,186 shares of Idexx Laboratories worth $1.64M as of Q1 2015.
Boston Private Bank & Trust sold 250 Idexx Laboratories shares in Q1 2015, an estimated $19.5K.
Idexx Laboratories made up 0.08% of Boston Private Bank & Trust's portfolio in Q1 2015, its #200 holding.
Boston Private Bank & Trust first reported a position in Idexx Laboratories in Q2 2013 and has held it in 8 quarters since.
344 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.